Unique Perspectives in Cancer Signaling
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 10535
Special Issue Editor
2. Graduate Program of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI 96813, USA
Interests: cancer signaling; cancer etiology; Fanconi anemia (FA) signaling; cancer treatment; genetic model; cancer genetics and biology
Special Issue Information
Dear Colleagues,
We are pleased to introduce a Special Issue on cancer signaling with a focus on unique, interdisciplinary perspectives for investigating key pathways that drive cancer initiation and progression. These perspectives can entail novel technological–computational implementations, translational–clinical-level applications, or even epidemiological enhancements of basic science understandings. Across these diverse inquiries, this edition on “Cancer Signaling” aims to define nuanced contexts surrounding oncogenic signaling for the development of therapeutic and preventive strategies against various cancers. Reviews are expected to focus on specific disease types or signaling pathways through a multidisciplinary lens. Original research articles with a focus along these scopes will also be considered.
Dr. Peiwen Fei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncogenesis
- cancer signaling
- technology
- translational
- clinical
- epidemiology